Document ID: chunk:federal_register_of_legislation:F2023C00019:front:0:p2
Version: federal_register_of_legislation:F2023C00019
Segment Type: other
Provision Reference: 
Character Range: 3120–4783

16  Advertisements—therapeutic goods not available for purchase by general public
            17  Advertisements—short form
          Division 3—Mandatory statements and other required information for other advertisements
            18  Application of this Division
            19  Advertisements—medicines
            20  Advertisements—medical devices
            21  Advertisements—other therapeutic goods

     Part 5—Additional requirements for advertisements about particular therapeutic goods
            22  Application of this Part
            23  Additional requirements for particular therapeutic goods

     Part 6Testimonials and endorsements
            24  Testimonials and endorsements

     Part 7Samples and incentives
            25  Samples
            26  Incentives

     Part 8Restricted representations
            27  Simplified outline of this Part
            28  Restricted representations—serious form of disease, condition, ailment or defect
            29  Restricted representations—public interest criteria

     Part 9—Price information
            30  Simplified outline of this Part
            31  Application of this Part
            32  Publication or dissemination of price information
            33  Presentation of price information
            34  Description of medicines
            35  General restrictions
            36  Medicines listed in the pharmaceutical benefits scheme

     Annexure 1—Advertising to children

     Annexure 2—Samples

     Endnotes
          Endnote 1—About the endnotes
          Endnote 2—Abbreviation key
          Endnote 3—Legislation history
          Endnote 4—Amendment history